We are live on ! Find out more
ETRM

EnteroMedics Inc.
ETRM

Delisted

ETRM was delisted on the 20th of October, 2017.

Back to rankings

56 hedge funds and large institutions have $23.5M invested in EnteroMedics Inc. in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

948% more call options, than puts

Call options by funds: $1.55M | Put options by funds: $148K

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

2% less funds holding

Funds holding: 57 → 56 (-1)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

38% less capital invested

Capital invested by funds: $38.1M → $23.5M (-$14.6M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
56
Holders Change
-1
Holders Change %
-1.75%
% of All Funds
1.61%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
12
Reduced
15
Closed
15
Calls
$1.55M
Puts
$148K
Net Calls
+$1.4M
Net Calls Change
+$123K

Top Buyers

Rank Fund Capital Flow
1
FAM
Fred Alger Management
New York
+$1.16M
2
SC
Sophrosyne Capital
New York
+$535K
3
JGC
J. Goldman & Co
New York
+$374K
4
RSCM
Rock Springs Capital Management
Maryland
+$357K
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$180K

Top Sellers

Rank Fund Capital Flow
1
AAP
Ardsley Advisory Partners
Connecticut
-$6.44M
2
Wells Fargo
Wells Fargo
California
-$1.94M
3
IHM
Iguana Healthcare Management
New York
-$980K
4
WPC
White Pine Capital
Minnesota
-$738K
5
GTC
Ghost Tree Capital
New York
-$728K
Name Holding Trade Value Shares
Change 		Change in
Stake
LTFS
51
Ladenburg Thalmann Financial Services
Florida
$4K +$3.74K +2 New
BNP Paribas Financial Markets
52
BNP Paribas Financial Markets
France
$3.66K – – –
Ameriprise
53
Ameriprise
Minnesota
$2K – – –
US Bancorp
54
US Bancorp
Minnesota
$2K +$1.87K +1 New
PRCM
55
Pine River Capital Management
Minnesota
$2K +$20.6K +11 New
AIG
56
American International Group
New York
$1.56K – – –
WPC
57
White Pine Capital
Minnesota
– -$738K -386 Closed
GTC
58
Ghost Tree Capital
New York
– -$728K -381 Closed
WMSA
59
Weiss Multi-Strategy Advisers
New York
– -$582K -305 Closed
PCM
60
Potomac Capital Management
New York
– -$307K -161 Closed
GGHC
61
Gilder Gagnon Howe & Co
New York
– -$148K -78 Closed
WAM
62
Wolverine Asset Management
Illinois
– -$121K -63 Closed
DCM
63
Driehaus Capital Management
Illinois
– -$111K -58 Closed
Verition Fund Management
64
Verition Fund Management
Connecticut
– -$98K -51 Closed
EA
65
Emerald Advisers
Pennsylvania
– -$63K -33 Closed
LOM
66
Loeb Offshore Management
New York
– -$55K -29 Closed
Nomura Holdings
67
Nomura Holdings
Japan
– -$50K -26 Closed
CA
68
Commerzbank Aktiengesellschaft
Germany
– -$37K -20 Closed
OAM
69
Oxford Asset Management
United Kingdom
– -$26K -14 Closed
CS
70
Credit Suisse
Switzerland
– -$21K -11 Closed
CCS
71
Crosspoint Capital Strategies
California
– -$7K -4 Closed
1 2
3

ETRM Hedge Fund Activity: Q2 2014 in Review

56 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q2 2014, worth a combined $23.5M — down 38% from $38.1M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of ETRM and 14 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 12 added.

The largest buyer was Fred Alger Management, opening a new position worth an estimated $1.16M. The largest seller was Ardsley Advisory Partners, cutting an estimated $6.44M.

  • 56 institutional investors held EnteroMedics Inc. (ETRM) as of Q2 2014, down from 57 in Q1 2014.
  • Funds reported $23.5M of EnteroMedics Inc. stock for Q2 2014, down 38% quarter-over-quarter.
  • 14 funds opened new EnteroMedics Inc. positions in Q2 2014 and 15 closed out, a net change of -1 holder.
  • The largest EnteroMedics Inc. buyer in Q2 2014 was Fred Alger Management, an estimated $1.16M added.
  • The largest EnteroMedics Inc. seller in Q2 2014 was Ardsley Advisory Partners, an estimated $6.44M sold.

Based on aggregated 13F filings for Q2 2014.